Raymond Furey | executive |
Raul Rodriguez | executive |
David Santos | executive |
Dean Schorno | executive |
Nalin Tejavibulya | analyst |
Rick Miller | analyst |
Carly Kenselaar | analyst |
Joseph Pantginis | analyst |
Greetings and welcome to Rigel Pharmaceuticals financial conference call for the third quarter of 2023. [Operator Instructions] A brief question-and-answer session will follow the formal presentation. [Operator Instructions]As a reminder, this conference is being recorded.It's now my pleasure to introduce our first speaker, Ray Furey, Rigel's Executive Vice President, General Counsel and Corporate Secretary. Thank you. Mr. Furey, you may begin.